Clinical trial
Patient Characteristics, Treatment Patterns, and Resource Usage in Children Diagnosed With Central Precocious Puberty (CPP) in China
NCT05341128 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Characteristics, Treatment Patterns, and Resource Usage in Children Diagnosed With Central Precocious Puberty (CPP) in China
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 13, 2023
- Completion date
- August 27, 2025
- Enrollment
- 1,477 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
central precocious puberty